The US FDA has proposed changes to the standards of identity (SOI) for foods to permit the use of salt substitutes.
Product developers would now have the flexibility to work with ingredients that are regulated by the SOI rule.
As SOIs require certain ingredients in the formulation, replacing salt with a salt substitute would be illegal.
There are over 250 SOI foods, including milk, milk chocolate, breads, cheeses and ketchup, with 80 of them specifying salt as a required or an optional ingredient.
The proposed rule does not list permitted salt substitutes but requires them to be “safe and suitable ingredients.” Potassium chloride is an often-used substitute. The agency also acknowledges the functional nature of salt.
According to the FDA, “the extent to which salt can be replaced depends on the ability of salt substitutes to replace the functions of salt in food without compromising the food safety or other essential characteristics of the food.”
The FDA''s 2021 voluntary sodium reduction targets for processed, packaged, and prepared foods seeks to reduce Americans' average daily intake of sodium from the current 3,300mg per day to 3,000 per day and ultimately to 2,300mg per day.
The proposed rule, "Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods," should be published shortly in the Federal Register, after which the industry and public will have 120 days to comment.


Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight
Asian Stocks Rally as Cooling US Inflation Boosts Fed Rate Outlook
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
France Inflation Rises 2.4% in July as Consumer Prices Increase
Gold Prices Slip From Two-Month High as Inflation and Fed Outlook Drive Markets
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Gold Prices Retreat From Two-Month High as Softer Inflation Eases Fed Rate Hike Bets
Stripe, Advent Reportedly Pursue $53 Billion PayPal Takeover
Anthropic Eyes $6B Decart AI Acquisition Ahead of Mega IPO
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
LG, Nvidia Expand AI Partnership With Humanoid Robots, AI Factories
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Asian Currencies Steady Ahead of US CPI as Oil Prices Rise 



